Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Lymphocytopenia”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Not applicableStudy completedNCT03549546
What this trial is testing

Expression of the Inhibitory Receptors on Lymphocytes T Cells After Lung Cancer Surgery.

Who this might be right for
Lung CancerSurgery
Centre Hospitalier Universitaire de Saint Etienne 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT03519464
What this trial is testing

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytopenia

Who this might be right for
Idiopathic CD4 T Cell Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Ended earlyNCT00839436
What this trial is testing

Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

Who this might be right for
Idiopathic CD4+ T-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 21
Not applicableStudy completedNCT00845416
What this trial is testing

Newborn Screening for Severe Combined Immunodeficiency (SCID) in a High-Risk Population

Who this might be right for
Severe Combined ImmunodeficiencyT Cell Lymphocytopenia
University of California, San Francisco 1,800
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT04578210
What this trial is testing

Safety Infusion of NatuRal KillEr celLs or MEmory T Cells as Adoptive Therapy in COVID-19 pnEumonia or Lymphopenia

Who this might be right for
Corona Virus Infection
Instituto de Investigación Hospital Universitario La Paz 84
Not applicableStudy completedNCT01306188
What this trial is testing

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

Who this might be right for
Breast CancerLung Cancer
Centre Leon Berard 179
Early research (Phase 1)Study completedNCT00477321
What this trial is testing

Safety Study of IL-7 in HIV-infected Patients (Inspire)

Who this might be right for
HIV InfectionsLymphopenia
Cytheris SA 30
Not applicableLooking for participantsNCT03394053
What this trial is testing

The Mechanistic Biology of Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Disorders
National Institute of Allergy and Infectious Diseases (NIAID) 2,500
Early research (Phase 1)Study completedNCT00693095
What this trial is testing

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer

Who this might be right for
Glioblastoma
John Sampson 23
Testing effectiveness (Phase 2)Enrolling By InvitationNCT01852370
What this trial is testing

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Who this might be right for
Severe Combined Immunodeficiency (SCID)Immunodeficiency With Predominant T-cell Defect, UnspecifiedSevere Chronic Neutropenia+6 more
Paul Szabolcs 16
Testing effectiveness (Phase 2)Looking for participantsNCT05600920
What this trial is testing

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00626483
What this trial is testing

Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

Who this might be right for
Malignant Neoplasms Brain
Gary Archer Ph.D. 34
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Early research (Phase 1)Looking for participantsNCT04097561
What this trial is testing

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07492875
What this trial is testing

Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Who this might be right for
Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis+2 more
ImmunityBio, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Early research (Phase 1)Study completedNCT00684008
What this trial is testing

Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant

Who this might be right for
AMLCMLMDS
Cytheris, Inc. 12
Testing effectiveness (Phase 2)Looking for participantsNCT02015013
What this trial is testing

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Who this might be right for
Idiopathic CD4-PositiveT-Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID) 40
Load More Results